Our study reveals significant alterations in PTEN chromatin interactions within TNBC tumors, providing a structural basis for the dysregulated PI3K/AKT signaling commonly observed in this aggressive breast cancer subtype. The gene discussed is AKT1; the disease is breast carcinoma.